United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 2, 2026 · Filed Apr 6, 2026

On Apr 2, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$561.37 for US$5.33M under a trading plan, leaving 40,513 shares. Filed Apr 6, 2026 (Form 4).

Sold
9,500 shares
Price
US$561.37 average (US$552.25 to US$571.66)
Value
US$5.33M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 2, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 2, 2026Common StockSale65US$552.2549,948Direct
Apr 2, 2026Common StockSale175US$553.5049,773Direct
Apr 2, 2026Common StockSale394US$554.4549,379Direct
Apr 2, 2026Common StockSale1,058US$555.4148,321Direct
Apr 2, 2026Common StockSale808US$556.5247,513Direct
Apr 2, 2026Common StockSale780US$557.4046,733Direct
Apr 2, 2026Common StockSale440US$558.5146,293Direct
Apr 2, 2026Common StockSale40US$559.9846,253Direct
Apr 2, 2026Common StockSale570US$561.6045,683Direct
Apr 2, 2026Common StockSale378US$562.4945,305Direct
Apr 2, 2026Common StockSale865US$563.5244,440Direct
Apr 2, 2026Common StockSale1,918US$564.5542,522Direct
Apr 2, 2026Common StockSale811US$565.3841,711Direct
Apr 2, 2026Common StockSale570US$566.3941,141Direct
Apr 2, 2026Common StockSale308US$567.7040,833Direct
Apr 2, 2026Common StockSale120US$568.5340,713Direct
Apr 2, 2026Common StockSale80US$570.0540,633Direct
Apr 2, 2026Common StockSale120US$571.6640,513Direct

Source

View original at SEC

Related